The cord blood banking industry is a complex industry, with numerous benchmarks that indicate the overall health of the industry, including public and private storage of cord blood and cord tissue units, utilization rates for cord blood, regional and global rates of hematopoietic stem cell transplantation (HSCT), and more.
Benchmarks are critical to assess, because the global cord blood market has matured substantially over the past few years, creating both serious threats and novel opportunities. Therefore, judging individual company performance relative to the broader cord blood marketplace has become substantially more complex.
Serious threats to the cord blood industry include:
[Read more…]